Tasly Pharmaceutical Group Co., Ltd. engages in biological medicine, health, and medical service businesses in China. It offers herbal and chemical medicines, health products, pharmaceutical substances and APIs, herbal extracts, concentrated herbal granules, and tea series products. The company also provides cosmetic series products, including moisture lotions, moisture creams, eye creams, and face washing foams; daily hygiene products, such as sanitary and carefree pads, honey-propolis soaps, and pollen soaps; and medical equipment, which include massage tappers, massage cushions, and circulation machines. It also exports its products to the United States, Russia, and countries in Europe, Africa, and rest of Asia. Tasly Pharmaceutical Group Co., Ltd. was founded in 1994 and is based in Tianjin, China.
Tasly Pharmaceutical Dividend Announcement
• Tasly Pharmaceutical announced a quarterly dividend of ¥0.07 per ordinary share which will be made payable on 2024-12-06. Ex dividend date: 2024-12-06
• Tasly Pharmaceutical annual dividend for 2024 was ¥0.66
• Tasly Pharmaceutical annual dividend for 2023 was ¥0.33
• Tasly Pharmaceutical 's trailing twelve-month (TTM) dividend yield is 4.57%
• Tasly Pharmaceutical 's payout ratio for the trailing twelve months (TTM) is 115.81%
• Tasly Pharmaceutical 's dividend growth over the last five years (2018-2023) was 2.92% year
• Tasly Pharmaceutical 's dividend growth over the last ten years (2013-2023) was 5.14% year
Tasly Pharmaceutical Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-12-06 | ¥0.07 | quarterly | 2024-12-06 |
2024-10-10 | ¥0.26 | quarterly | 2024-10-10 |
2024-05-29 | ¥0.33 | quarterly | 2024-05-29 |
2023-05-22 | ¥0.33 | quarterly | 2023-05-22 |
2022-06-20 | ¥0.33 | quarterly | 2022-06-20 |
2021-06-24 | ¥0.33 | quarterly | 2021-06-24 |
2020-06-12 | ¥0.33 | quarterly | 2020-06-12 |
2019-06-13 | ¥0.30 | quarterly | 2019-06-13 |
2018-06-05 | ¥0.29 | quarterly | 2018-06-05 |
2017-06-15 | ¥0.56 | quarterly | 2017-06-15 |
2016-05-25 | ¥0.42 | quarterly | |
2015-05-21 | ¥0.39 | quarterly | |
2014-06-19 | ¥0.35 | quarterly | |
2013-05-22 | ¥0.20 | quarterly |
Tasly Pharmaceutical Dividend per year
Tasly Pharmaceutical Dividend growth
Tasly Pharmaceutical Dividend Yield
Tasly Pharmaceutical current trailing twelve-month (TTM) dividend yield is 4.57%. Interested in purchasing Tasly Pharmaceutical stock? Use our calculator to estimate your expected dividend yield:
Tasly Pharmaceutical Financial Ratios
Tasly Pharmaceutical Dividend FAQ
Other factors to consider when evaluating Tasly Pharmaceutical as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Tasly Pharmaceutical stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Tasly Pharmaceutical 's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Tasly Pharmaceutical publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Tasly Pharmaceutical distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Tasly Pharmaceutical are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Tasly Pharmaceutical sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Tasly Pharmaceutical distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Tasly Pharmaceutical declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Tasly Pharmaceutical 's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Tasly Pharmaceutical 's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.